These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Impact of immunosuppression on the development of Epstein-Barr virus (EBV) viremia after pediatric liver transplantation. Lu BR, Park KT, Hurwitz M, Cox KL, Berquist WE. Transplant Proc; 2013 Feb; 45(1):301-4. PubMed ID: 23267800 [Abstract] [Full Text] [Related]
29. Umbilical Cord Blood Transplantation without Antithymocyte Globulin Results in Similar Survival but Better Quality of Life Compared with Unrelated Peripheral Blood Stem Cell Transplantation for the Treatment of Acute Leukemia-A Retrospective Study in China. Tong J, Xuan L, Sun Y, Huang D, Liu H, Zheng C, Zhu X, Tang B, Song K, Zhang X, Zhang L, Yao W, Lin D, Liu Q, Sun Z. Biol Blood Marrow Transplant; 2017 Sep; 23(9):1541-1548. PubMed ID: 28499936 [Abstract] [Full Text] [Related]
30. Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: a single-center experience. Luo L, Zhang L, Cai B, Li H, Huang W, Jing Y, Zhu H, Zhao Y, Bo J, Wang Q, Han X, Yu L, Gao C. Ann Transplant; 2014 Jan 08; 19():6-12. PubMed ID: 24399278 [Abstract] [Full Text] [Related]
31. Long-term outcome of Epstein-Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT. Kinch A, Hallböök H, Arvidson J, Sällström K, Bondeson K, Pauksens K. Leuk Lymphoma; 2018 May 08; 59(5):1172-1179. PubMed ID: 28831836 [Abstract] [Full Text] [Related]
32. Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. Cao S, Cox K, Esquivel CO, Berquist W, Concepcion W, Ojogho O, Monge H, Krams S, Martinez O, So S. Transplantation; 1998 Oct 15; 66(7):851-6. PubMed ID: 9798693 [Abstract] [Full Text] [Related]
33. Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation. Pagliuca S, Bommier C, Michonneau D, Meignin V, Salmona M, Robin M, Prata PH, Xhaard A, de Fontbrune FS, Feghoul L, Dhedin N, de Latour RP, Caillat-Zucman S, Goff JL, Socié G. Biol Blood Marrow Transplant; 2019 Dec 15; 25(12):2490-2500. PubMed ID: 31421238 [Abstract] [Full Text] [Related]
36. Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis. Mehra V, Rhone E, Widya S, Zuckerman M, Potter V, Raj K, Kulasekararaj A, McLornan D, de Lavallade H, Benson-Quarm N, Lim C, Ware S, Sudhanva M, Malik O, Nicholas R, Muraro PA, Marsh J, Mufti GJ, Silber E, Pagliuca A, Kazmi MA. Clin Infect Dis; 2019 Oct 30; 69(10):1757-1763. PubMed ID: 30980715 [Abstract] [Full Text] [Related]
37. Hemophagocytic lymphohistiocytosis is a sign of poor outcome in pediatric Epstein-Barr virus-associated post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation. Ali S, AlThubaiti S, Renzi S, Krueger J, Chiang KY, Naqvi A, Schechter T, Punnett A, Ali M. Pediatr Transplant; 2019 Feb 30; 23(1):e13319. PubMed ID: 30417487 [Abstract] [Full Text] [Related]
38. Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β- and CD19-Depleted Grafts. Laberko A, Bogoyavlenskaya A, Shelikhova L, Shekhovtsova Z, Balashov D, Voronin K, Kurnikova E, Boyakova E, Raykina E, Brilliantova V, Pirumova V, Novichkova G, Maschan A, Maschan M. Biol Blood Marrow Transplant; 2017 Mar 30; 23(3):483-490. PubMed ID: 28039080 [Abstract] [Full Text] [Related]